Double Medical Technology grants reserved stock options, adjusts plan price

Double Medical Technology, under stock code 002901, announced the grant of 620,400 reserved stock options to 89 incentive participants. Effective September 17, 2025, the options have an exercise price of CNY 23.39 per option, representing 0.15% of the company's total share capital at the time of grant. The options are sourced from newly issued or repurchased shares.

This decision follows the company's 2024 annual general meeting on May 21, 2025, which approved a profit distribution plan of CNY 5.00 per 10 shares. This dividend led to an adjustment of the exercise price for all previously granted options from CNY 23.89 to CNY 23.39. The adjustment applies to 681 incentive participants for 7,128,000 options. These actions were approved by the board of directors and the supervisory board on September 17, 2025.

The total predicted expense for the 6,204,000 reserved options is CNY 19,815,600, to be amortized over 2025, 2026, and 2027. The company's performance targets for the options include achieving net profits of not less than CNY 250 million in 2024, CNY 315 million in 2025, and CNY 400 million in 2026.